NF-κB-binding activity in an animal diet-induced overweightness model and the impact of subsequent energy restriction

Biochemical and Biophysical Research Communications

Volumn 311, Issue 2, 2003, Pages 533-539

  Lamas, O ^a   Moreno Aliaga, M J ^a   Martinez, J A ^a   Marti, A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

DNA binding activity; Gel shift assay; Nuclear factor B; Peroxisome proliferator activated receptor 1; Sterol regulatory element binding protein 1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIET; DNA BINDING; GENE CONTROL; IMMUNE RESPONSE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN;

ANIMALIA;

EID: 0242299740     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.10.028     Document Type: Article

References (37)

1. Campbell I. The obesity epidemic: can we turn the tide? Heart. 89:2003;22-37.
2. National Institutes of Health Consensus Development Panel on the Health implications of Obesity, Health implications of obesity: National Institutes of Health consensus development conference statement, Ann. Intern. Med. 103 (2003) 1073-1077.
3. Feinleib M. Epidemiology of obesity in relation to health hazards. Ann. Intern. Med. 103:1985;1019-1024.
4. Kannel W.B., Brand N., Skinner J., Dawber T.R., McNamara P.M. The relation of obesity to blood pressure and development of hypertension: the Framingham study. Ann. Intern. Med. 67:1967;48-59.
5. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348:2003;1625-1638.
6. Weber D.J., Rutala W.A., Samsa G.P., Santimaw J.E., Lemon S.M. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA. 254:1985;3187-3189.
7. Weber D.J., Rutala W.A., Samsa G.P., Bradshaw S.E., Lemon S.M. Impaired immunogenicity of hepatitis B vaccine in obese persons [letter]. N. Engl. J. Med. 314:1986;1393.
8. Lamas O., Martínez J.A., Marti A. T helper lymphopenia and decreased mitogenic response in cafeteria diet-induced obese rats. Nutr. Res. 22:2002;496-507.
9. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
10. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 18:1999;6867-6874.
11. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89:1997;331-340.
12. k and SREBP genes in mononuclear cells from acute leukemia patients. Leuk. Res. 24:2000;913-916.
13. Kim J.B., Wright H.M., Wright M., Spiegelman B.M. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proc. Natl. Acad. Sci. USA. 95:1998;4333-4337.
14. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature. 405:2000;421-424.
15. Willson T.M., Brown P.J., Sternbach D.D., Henke B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43:2000;527-550.
16. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 358:1992;771-774.
17. Palmer C.N., Hsu M.H., Griffin H.J., Johnson E.F. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270:1995;16114-16121.
18. Murphy G.J., Holder J.C. PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol. Sci. 21:2000;469-474.
19. Kassam A., Hunter J., Rachubinski R.A., Capone J.P. Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma. Mol. Cell. Endocrinol. 141:1998;153-162.
20. Li M., Pascual G., Glass C.K. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell. Biol. 20:2000;4699-4707.
21. Clark R.B., Bishop-Bailey D., Estrada-Hernandez T., Hla T., Puddington L., Padula S.J. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J. Immunol. 164:2000;1364-1371.
22. Diab A., Deng C., Smith J.D., Hussain R.Z., Phanavanh B., Lovett-Racke A.E., Drew P.D., Racke M.K. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy- Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 168:2002;2508-2515.
23. Castrillo A., Diaz-Guerra M.J., Hortelano S., Martin-Sanz P., Bosca L. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy- Delta(12,14)-prostaglandin J(2) in activated murine macrophages. Mol. Cell. Biol. 20:2000;1692-1698.
24. Straus D.S., Pascual G., Li M., Welch J.S., Ricote M., Hsiang C.H. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl. Acad. Sci. USA. 97:2000;4844-4849.
25. Berraondo B., Marti A., Duncan J.S., Trayhurn P., Martinez J.A. Up-regulation of muscle UCP2 gene expression by a new beta3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animals. Int. J. Obes. 24:2000;156-163.
26. Corbalán M.S., Margareto J., Martínez J.A., Marti A. High-fat feeding reduced muscle uncoupling protein 3 expression in rats. J. Physiol. Biochem. 55:1999;67-72.
27. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
28. Lavery D.J., Schibler U. Circadian transcription of the cholesterol 7 alpha hydroxylase gene may involve the liver-enriched bZIP protein DBP. Genes Dev. 7:1993;1871-1884.
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
30. Lamas O., Marti A., Martinez J.A. Obesity and immunocompetence. Eur. J. Clin. Nutr. 56(S3):2002;S42-S45.
31. Tracey V.V., De N.C., Harper J.R. Obesity and respiratory infection in infants and young children. Br. Med. J. 1:1971;16-18.
32. Clark R.B. The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 71:2002;388-400.
33. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
34. Kawahito Y., Kondo M., Tsubouchi Y., Hashiramoto A., Bishop-Bailey D., Inoue K., Kohno M., Yamada R., Hla T., Sano H. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J. Clin. Invest. 106:2000;189-197.
35. Yang X.Y., Wang L.H., Chen T., Hodge D.R., Resau J.H., DaSilva L., Farrar W.L. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J. Biol. Chem. 275:2000;4541-4544.
36. O. Lamas, J.A. Martínez, A. Marti, Energy restriction restores the impaired immune response in overweight (cafeteria) rats. J. Nutr. Biochem. (in press).
37. Faveeuw C., Fougeray S., Angeli V., Fontaine J., Chinetti G., Gosset P., Delerive P., Maliszewski C., Capron M., Staels B., Moser M., Trottein F. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett. 486:2000;261-266.